Hsbc Holdings PLC Has $2.46 Million Stake in Concentrix Corporation $CNXC

Hsbc Holdings PLC increased its stake in Concentrix Corporation (NASDAQ:CNXC) by 60.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,134 shares of the company’s stock after acquiring an additional 22,187 shares during the quarter. Hsbc Holdings PLC owned 0.10% of Concentrix worth $2,459,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Thompson Investment Management Inc. increased its position in Concentrix by 36.9% in the 4th quarter. Thompson Investment Management Inc. now owns 216,154 shares of the company’s stock valued at $8,988,000 after buying an additional 58,251 shares in the last quarter. Invenomic Capital Management LP raised its stake in Concentrix by 19.7% during the 3rd quarter. Invenomic Capital Management LP now owns 822,345 shares of the company’s stock worth $37,951,000 after buying an additional 135,429 shares during the period. Crossmark Global Holdings Inc. boosted its holdings in Concentrix by 189.5% in the third quarter. Crossmark Global Holdings Inc. now owns 77,128 shares of the company’s stock worth $3,559,000 after acquiring an additional 50,482 shares in the last quarter. Hussman Strategic Advisors Inc. boosted its holdings in Concentrix by 100.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company’s stock worth $3,493,000 after acquiring an additional 42,000 shares in the last quarter. Finally, Pzena Investment Management LLC grew its stake in Concentrix by 32.3% in the fourth quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock valued at $121,713,000 after acquiring an additional 714,604 shares during the period. Institutional investors and hedge funds own 90.34% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Andre S. Valentine purchased 2,500 shares of Concentrix stock in a transaction that occurred on Thursday, April 9th. The stock was bought at an average price of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the transaction, the chief financial officer owned 89,066 shares in the company, valued at $2,489,394.70. This represents a 2.89% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the transaction, the insider owned 2,773,667 shares of the company’s stock, valued at approximately $61,714,090.75. The trade was a 68.39% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.90% of the company’s stock.

Key Stories Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Negative Sentiment: Concentrix lowered its FY2026 and Q3 2026 guidance below Wall Street expectations, signaling slower demand as clients trim spending. The company now expects FY2026 EPS of $10.83-$11.18 versus consensus near $11.45, and revenue of $9.9 billion-$10.0 billion versus about $10.1 billion. Article: Reuters – Concentrix cuts annual forecast as clients trim spend; shares fall
• Negative Sentiment: Q2 earnings and revenue came in just below estimates, with EPS of $2.63 versus $2.64 expected and revenue of $2.46 billion versus $2.47 billion expected. That small miss adds to investor concern that growth is slowing. Article: Zacks – Concentrix Corporation (CNXC) Misses Q2 Earnings and Revenue Estimates
• Neutral Sentiment: Management highlighted better cash generation and iX Suite momentum, including record quarterly cash from operations of $258 million, adjusted free cash flow of $242 million, and strong growth in iX Suite deals. The company also targeted $630 million-$650 million in FY2026 adjusted free cash flow and more than $120 million in iX Suite ARR, which could help support the stock over time. Article: MSN – Concentrix posts Q2 CY2026 sales in line with estimates but stock drops 24%

Analysts Set New Price Targets

CNXC has been the subject of several recent research reports. Wall Street Zen downgraded Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a report on Monday, April 27th. Canaccord Genuity Group reduced their price target on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, March 25th. Barrington Research restated an “outperform” rating and set a $38.00 price target on shares of Concentrix in a research note on Monday, June 22nd. Finally, Robert W. Baird lowered their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a report on Wednesday, March 25th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $44.33.

Concentrix Stock Performance

CNXC stock opened at $25.23 on Tuesday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.43. The firm has a market cap of $1.54 billion, a PE ratio of -1.17, a P/E/G ratio of 0.31 and a beta of 0.43. The business has a 50 day moving average of $25.84 and a 200-day moving average of $32.08. Concentrix Corporation has a 12-month low of $22.05 and a 12-month high of $62.14.

Concentrix (NASDAQ:CNXC) last issued its quarterly earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The business had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.47 billion. During the same quarter last year, the business posted $2.70 earnings per share. The business’s revenue was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. As a group, sell-side analysts expect that Concentrix Corporation will post 10.42 earnings per share for the current year.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.